Gonzalo Martinez de la Escalera (Gonzalo Martínez de la Escalera)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Inflammatory Response

Oxidative Stress

Top Venues

Neurochemical research

Journal of neuroendocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Miriam Ulloa, Fernando Macías, Carmen Clapp, Gonzalo Martinez de la Escalera, Edith Arnold
Prolactin is an Endogenous Antioxidant Factor in Astrocytes That Limits Oxidative Stress-Induced Astrocytic Cell Death via the STAT3/NRF2 Signaling Pathway. Neurochemical research 49 (7) (2024)
Miriam Ulloa, Fernando Macías, Carmen Clapp, Gonzalo Martinez de la Escalera, Edith Arnold
Prolactin is an Endogenous Antioxidant Factor in Astrocytes That Limits Oxidative Stress-Induced Astrocytic Cell Death via the STAT3/NRF2 Signaling Pathway. Neurochemical research 49 (7) (2024)
Miriam Ulloa, Fernando Macías, Carmen Clapp, Gonzalo Martinez de la Escalera, Edith Arnold
Prolactin is an Endogenous Antioxidant Factor in Astrocytes That Limits Oxidative Stress-Induced Astrocytic Cell Death via the STAT3/NRF2 Signaling Pathway. Neurochemical research 49 (7) (2024)
Miriam Ulloa, Fernando Macías, Carmen Clapp, Gonzalo Martinez de la Escalera, Edith Arnold
Prolactin is an Endogenous Antioxidant Factor in Astrocytes That Limits Oxidative Stress-Induced Astrocytic Cell Death via the STAT3/NRF2 Signaling Pathway. Neurochemical research 49 (7) (2024)
Ximena Castillo, Georgina Ortiz, Edith Arnold, Zhijian Wu, Luis B Tovar-Y-Romo, Carmen Clapp, Gonzalo Martinez de la Escalera
The influence of the prolactin/vasoinhibin axis on post-stroke lesion volume, astrogliosis, and survival. Journal of neuroendocrinology (2024)
Miriam Ulloa, Fernando Macías, Carmen Clapp, Gonzalo Martinez de la Escalera, Edith Arnold
Prolactin is an Endogenous Antioxidant Factor in Astrocytes That Limits Oxidative Stress-Induced Astrocytic Cell Death via the STAT3/NRF2 Signaling Pathway. Neurochemical research 49 (7) (2024)
Miriam Ulloa, Fernando Macías, Carmen Clapp, Gonzalo Martinez de la Escalera, Edith Arnold
Prolactin is an Endogenous Antioxidant Factor in Astrocytes That Limits Oxidative Stress-Induced Astrocytic Cell Death via the STAT3/NRF2 Signaling Pathway. Neurochemical research (2024)
Juan Pablo Robles, Magdalena Zamora, Jose Fernando García-Rodrigo, Alma Lorena Perez, Thomas Bertsch, Gonzalo Martinez de la Escalera, Jakob Triebel, Carmen Clapp
Vasoinhibin apoptotic, inflammatory, and fibrinolytic actions are in a motif different from its antiangiogenic HGR motif. Endocrinology (2023)
Jose Fernando García-Rodrigo, Georgina Ortiz, Oscar Fernando Martínez-Díaz, Janette Furuzawa-Carballeda, Xarubet Ruíz-Herrera, Fernando Macias, Maria G Ledesma-Colunga, Gonzalo Martinez de la Escalera, Carmen Clapp
Prolactin inhibits or stimulates the inflammatory response of joint tissues in a cytokine-dependent manner. Endocrinology (2023)
Gonzalo Martinez de la Escalera, Yazmin Macotela, Carmen Clapp
A New Experimental Tool Toward Understanding the Regulation of Human Prolactin Secretion and Functions. Endocrinology 163 (4) (2022)
Georgina Ortiz, Maria G Ledesma-Colunga, Zhijian Wu, Jose F García-Rodrigo, Norma Adan, Oscar F Martinez-Diaz, Ericka A De Los Ríos, Fernando López-Barrera, Gonzalo Martinez de la Escalera, Carmen Clapp
Vasoinhibin is Generated and Promotes Inflammation in Mild Antigen-induced Arthritis. Endocrinology 163 (5) (2022)
Magdalena Zamora, Juan Pablo Robles, Manuel B Aguilar, Sergio de Jesús Romero-Gómez, Thomas Bertsch, Gonzalo Martinez de la Escalera, Jakob Triebel, Carmen Clapp
Thrombin Cleaves Prolactin Into a Potent 5.6-kDa Vasoinhibin: Implication for Tissue Repair. Endocrinology 162 (12) (2022)
Juan Pablo Robles, Magdalena Zamora, Lourdes Siqueiros-Marquez, Elva Adan-Castro, Gabriela Ramirez-Hernandez, Francisco Freinet Nuñez, Fernando Lopez-Casillas, Robert P Millar, Thomas Bertsch, Gonzalo Martinez de la Escalera, Jakob Triebel, Carmen Clapp
The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide. Angiogenesis (2021)